Restarting anticoagulation early versus late in patients with chronic subdural hematoma and atrial fibrillation (RELACS) : a phase III international multicenter, randomized controlled, two-arm, assessor-blinded trial
Background: Chronic subdural hematoma (CSDH) is a rapidly growing neurosurgical condition, driven primarily by an aging population and the increasing use of antithrombotic medications. Approximately 25% of CSDH patients are on anticoagulants due to atrial fibrillation (AF). The postoperative management of these patients presents a significant clinical challenge, as clinicians must balance the risk
